Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Antisense-mediated exon skipping for Duchenne muscular dystrophy. Edition No. 1

VDM Publishing House, Feb 2009, Pages: 120


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Duchenne muscular dystrophy (DMD) is a severe,
progressive muscle wasting disease for which there
is currently no cure. The disease is caused by
mutations in the DMD gene that completely abolish
the function of the protein dystrophin.
This thesis focuses on the development of a
promising new therapy, so called antisense-mediated
exon skipping, that aims to restore the disrupted
dystrophin reading frame to allow generation of
internally deleted, but partly functional dystrophin
proteins, as found in the less severe Becker
muscular dystrophy.
The thesis describes the DMD gene, the dystrophin
protein, diseases associated with mutations in the
DMD gene and animal models. It provides an overview
of potential therapies for Duchenne muscular
dystrophy and describes how antisense-mediated
modulation of splicing can be used for other
therapeutic and research purposes. Finally it gives
a detailed overview of the rationale and the
development of the exon skipping therapy for
Duchenne muscular dystrophy.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds